N-[7-bromo-1-(2-prop-2-enoyl-3,4,5,6-tetrahydrodiazepin-7-yl)benzimidazol-2-yl]-5-methylpyridine-3-carboxamide

C22H21BrN6O2 — CID 129290572

IUPACN-[7-bromo-1-(2-prop-2-enoyl-3,4,5,6-tetrahydrodiazepin-7-yl)benzimidazol-2-yl]-5-methylpyridine-3-carboxamide
SMILESC=CC(=O)N1CCCCC(n2c(NC(=O)c3cncc(C)c3)nc3cccc(Br)c32)=N1
InChIInChI=1S/C22H21BrN6O2/c1-3-19(30)28-10-5-4-9-18(27-28)29-20-16(23)7-6-8-17(20)25-22(29)26-21(31)15-11-14(2)12-24-13-15/h3,6-8,11-13H,1,4-5,9-10H2,2H3,(H,25,26,31)
InChIKeyLLNOOYXPNAWMTK-UHFFFAOYSA-N
MW481.35 g/mol
LogP4.11
Rot. Bonds3

About N-[7-bromo-1-(2-prop-2-enoyl-3,4,5,6-tetrahydrodiazepin-7-yl)benzimidazol-2-yl]-5-methylpyridine-3-carboxamide

N-[7-bromo-1-(2-prop-2-enoyl-3,4,5,6-tetrahydrodiazepin-7-yl)benzimidazol-2-yl]-5-methylpyridine-3-carboxamide (PubChem CID 129290572) has the molecular formula C22H21BrN6O2 and a molecular weight of 481.35 g/mol. Its IUPAC name is N-[7-bromo-1-(2-prop-2-enoyl-3,4,5,6-tetrahydrodiazepin-7-yl)benzimidazol-2-yl]-5-methylpyridine-3-carboxamide.

Molecular Properties

Compound NameN-[7-bromo-1-(2-prop-2-enoyl-3,4,5,6-tetrahydrodiazepin-7-yl)benzimidazol-2-yl]-5-methylpyridine-3-carboxamide
PubChem CID129290572
Molecular FormulaC22H21BrN6O2
Molecular Weight481.35 g/mol
Exact Mass480.09
IUPAC NameN-[7-bromo-1-(2-prop-2-enoyl-3,4,5,6-tetrahydrodiazepin-7-yl)benzimidazol-2-yl]-5-methylpyridine-3-carboxamide
SMILESC=CC(=O)N1CCCCC(n2c(NC(=O)c3cncc(C)c3)nc3cccc(Br)c32)=N1
InChIInChI=1S/C22H21BrN6O2/c1-3-19(30)28-10-5-4-9-18(27-28)29-20-16(23)7-6-8-17(20)25-22(29)26-21(31)15-11-14(2)12-24-13-15/h3,6-8,11-13H,1,4-5,9-10H2,2H3,(H,25,26,31)
InChIKeyLLNOOYXPNAWMTK-UHFFFAOYSA-N
XLogP4.11
TPSA92.48 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds3
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500481.35
LogP ≤ 54.11
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze N-[7-bromo-1-(2-prop-2-enoyl-3,4,5,6-tetrahydrodiazepin-7-yl)benzimidazol-2-yl]-5-methylpyridine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[7-bromo-1-(2-prop-2-enoyl-3,4,5,6-tetrahydrodiazepin-7-yl)benzimidazol-2-yl]-5-methylpyridine-3-carboxamide?
The IUPAC name of N-[7-bromo-1-(2-prop-2-enoyl-3,4,5,6-tetrahydrodiazepin-7-yl)benzimidazol-2-yl]-5-methylpyridine-3-carboxamide (CID 129290572) is N-[7-bromo-1-(2-prop-2-enoyl-3,4,5,6-tetrahydrodiazepin-7-yl)benzimidazol-2-yl]-5-methylpyridine-3-carboxamide.
What is the SMILES notation for N-[7-bromo-1-(2-prop-2-enoyl-3,4,5,6-tetrahydrodiazepin-7-yl)benzimidazol-2-yl]-5-methylpyridine-3-carboxamide?
The canonical SMILES for N-[7-bromo-1-(2-prop-2-enoyl-3,4,5,6-tetrahydrodiazepin-7-yl)benzimidazol-2-yl]-5-methylpyridine-3-carboxamide is C=CC(=O)N1CCCCC(n2c(NC(=O)c3cncc(C)c3)nc3cccc(Br)c32)=N1.
What is the InChIKey of N-[7-bromo-1-(2-prop-2-enoyl-3,4,5,6-tetrahydrodiazepin-7-yl)benzimidazol-2-yl]-5-methylpyridine-3-carboxamide?
The InChIKey is LLNOOYXPNAWMTK-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H21BrN6O2/c1-3-19(30)28-10-5-4-9-18(27-28)29-20-16(23)7-6-8-17(20)25-22(29)26-21(31)15-11-14(2)12-24-13-15/h3,6-8,11-13H,1,4-5,9-10H2,2H3,(H,25,26,31).
What are the key properties of N-[7-bromo-1-(2-prop-2-enoyl-3,4,5,6-tetrahydrodiazepin-7-yl)benzimidazol-2-yl]-5-methylpyridine-3-carboxamide?
N-[7-bromo-1-(2-prop-2-enoyl-3,4,5,6-tetrahydrodiazepin-7-yl)benzimidazol-2-yl]-5-methylpyridine-3-carboxamide has a molecular weight of 481.35 g/mol, XLogP of 4.11, 3 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[7-bromo-1-(2-prop-2-enoyl-3,4,5,6-tetrahydrodiazepin-7-yl)benzimidazol-2-yl]-5-methylpyridine-3-carboxamide is sourced from PubChem (CID 129290572), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).